<!DOCTYPE html>
<html>
    <head>
        <title>STD Tx Guidelines</title>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g406" data-theme="a">
            <div data-role="header" data-id="guidelines-header" data-theme="b" data-position="fixed">
                <a href="lv-404.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h3>STD Tx Guidelines</h3>
	<a href="../menu.html" class="ui-btn ui-icon-grid ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-0.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-402.html" >Sexual Assault and STDs</a><span class="carrot"> > </span>
                    <a href="lv-404.html" >Sexual Assault or Abuse of Children</a><span class="carrot"> > </span>
                    <a href="lv-404.html" >Evaluating Children for Sexually Transmitted Diseases</a><span class="carrot"> > </span>Recommendations for HIV-Related Postexposure Assessment of Children within 72 Hours of Sexual Assault
            </div>
            </br><h4 id="sigil_toc_id_406">
 Recommendations for HIV-Related Postexposure Assessment of Children within 72 Hours of Sexual Assault
</h4>
<p>
 &bull; Review HIV/AIDS local epidemiology and assess risk for HIV infection in the assailant.
</p>
<p>
 &bull; Evaluate circumstances of assault that might affect risk for HIV transmission.
</p>
<p>
 &bull; Consult with a specialist in treating HIV-infected children&nbsp;if PEP is considered.
</p>
<p>
 &bull; If the child appears to be at risk for HIV transmission from the assault, discuss PEP with the caregiver(s), including its toxicity and unknown efficacy.
</p>
<p>
 &bull; If caregivers choose for the child to receive antiretroviral PEP (78,142,489), provide enough medication to last until the return visit at 3&ndash;7 days after the initial assessment,&nbsp;at which time the child should be reevaluated and tolerance of medication assessed; dosages should not exceed those for adults.
</p>
<p>
 &bull; Perform HIV antibody test at original assessment, 6 weeks, 3 months, and 6 months.
</p>

            </div>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

